Inactivating mutations in PRKAR1A, a gene encoding the type 1 α-regulatory subunit (R1α) of the cAMP–dependent protein kinase (PKA) have been found in 80% of CNC patients with Cushing's syndrome. This evidence concerns the gene PRKAR1A and Cushing syndrome due to macronodular adrenal hyperplasia.